Latest Bellevue Group AG Stock Portfolio

Bellevue Group AG Performance:

2025 Q4: 11.69%YTD: 20.44%2024: 0.97%

Performance for 2025 Q4 is 11.69%, and YTD is 20.44%, and 2024 is 0.97%.

About Bellevue Group AG and 13F Hedge Fund Stock Holdings

On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, Bellevue Group AG reported an equity portfolio of $5.3 Billions as of 31 Dec, 2025.

The top stock holdings of Bellevue Group AG are RVMD, ARGX, IONS. The fund has invested 7.6% of it's portfolio in REVOLUTION MEDICINES INC and 7.4% of portfolio in ARGENX SE.

The fund managers got completely rid off AGIOS PHARMACEUTICALS INC (AGIO), AKERO THERAPEUTICS INC (AKRO) and BIOHAVEN LTD stocks. They significantly reduced their stock positions in INCYTE CORP (INCY), BEAM THERAPEUTICS INC (BEAM) and BEONE MEDICINES LTD (BGNE). Bellevue Group AG opened new stock positions in AMICUS THERAPEUTICS INC (FOLD), VIRIDIAN THERAPEUTICS INC (VRDN) and NUVALENT INC (NUVL). The fund showed a lot of confidence in some stocks as they added substantially to KRYSTAL BIOTECH INC (KRYS), CORCEPT THERAPEUTICS INC (CORT) and MICROSOFT CORP (MSFT).

Bellevue Group AG Annual Return Estimates Vs S&P 500

Our best estimate is that Bellevue Group AG made a return of 11.69% in the last quarter. In trailing 12 months, it's portfolio return was 20.44%.

Performance
S&P 500

New Buys

Ticker	$ Bought
amicus therapeutics inc	152,869,000
viridian therapeutics inc	135,637,000
nuvalent inc	104,359,000
vera therapeutics inc	85,994,400
jade biosciences inc	51,553,200
maze therapeutics inc	36,777,700
tango therapeutics inc	34,799,200
medline inc	4,944,240

New stocks bought by Bellevue Group AG

Additions

Ticker	% Inc.
krystal biotech inc	31,174
corcept therapeutics inc	755
microsoft corp	531
nvidia corporation	460
pfizer inc	380
glaukos corp	368
cytokinetics inc	339
ptc therapeutics inc	167

Additions to existing portfolio by Bellevue Group AG

Reductions

Ticker	% Reduced
incyte corp	-99.67
beam therapeutics inc	-96.14
beone medicines ltd	-94.41
exact sciences corp	-93.64
cencora inc	-89.26
encompass health corp	-84.48
quest diagnostics inc	-77.95
si-bone inc	-69.77

Bellevue Group AG reduced stake in above stock

Sold off

Ticker	$ Sold
macrogenics inc	-16,665,600
agios pharmaceuticals inc	-149,110,000
biohaven ltd	-42,070,800
akero therapeutics inc	-113,445,000
hologic inc	-16,729,800
baxter intl inc	-1,550,270
moonlake immunotherapeutics	-251,323
baidu inc	-263,540

Bellevue Group AG got rid off the above stocks

Sector Distribution

Bellevue Group AG has about 88% of it's holdings in Healthcare sector.

Sector	%
Healthcare	88
Others	11.8

Market Cap. Distribution

Bellevue Group AG has about 64.1% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	60.9
MID-CAP	17.6
UNALLOCATED	11.8
SMALL-CAP	6.2
MEGA-CAP	3.2

Stocks belong to which Index?

About 69.6% of the stocks held by Bellevue Group AG either belong to S&P 500 or RUSSELL 2000 index.

Index	%
S&P 500	35.4
RUSSELL 2000	34.2
Others	30.4

Top 5 Winners (%)		%
	structure therapeutics inc	108.3 %
WVE	wave life sciences ltd	90.2 %
RVMD	revolution medicines inc	67.0 %
ANNX	annexon inc	64.6 %
RLAY	relay therapeutics inc	62.1 %

Top 5 Winners ($)		$
RVMD	revolution medicines inc	174.3 M
IONS	ionis pharmaceuticals inc	75.6 M
RNA	avidity biosciences inc	68.3 M
ARGX	argenx se	52.1 M
ISRG	intuitive surgical inc	39.9 M

Top 5 Losers (%)		%
QURE	uniqure nv	-59.0 %
CORT	corcept therapeutics inc	-43.7 %
DOCS	doximity inc	-37.2 %
LEGN	legend biotech corp	-29.2 %
	tempus ai inc	-26.2 %

Top 5 Losers ($)		$
ALNY	alnylam pharmaceuticals inc	-26.0 M
ABT	abbott labs	-12.1 M
SYK	stryker corporation	-7.4 M
VEEV	veeva sys inc	-6.6 M
RMD	resmed inc	-5.4 M

Bellevue Group AG Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Bellevue Group AG

Bellevue Group AG has 176 stocks in it's portfolio. About 49.5% of the portfolio is in top 10 stocks. ALNY proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for Bellevue Group AG last quarter.

Last Reported on: 17 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
A	agilent technologies inc	0.00	350	47,625	reduced	-56.58

AAPL	apple inc	0.02	3,320	902,575	added	106

ABBV	abbvie inc	0.58	134,859	30,813,900	reduced	-21.08

ABC	cencora inc	0.00	521	175,968	reduced	-89.26

ABT	abbott labs	3.13	1,316,920	164,996,000	reduced	-10.93

ACN	accenture plc ireland	0.01	1,500	402,450	new

ADBE	adobe inc	0.01	1,200	419,988	new

ADPT	adaptive biotechnologies cor	0.09	298,090	4,840,980	added	76.93

AFK	vaneck etf trust	0.03	15,500	1,329,440	reduced	-16.22

AGIO	agios pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

AKRO	akero therapeutics inc	0.00	0.00	0.00	sold off	-100

ALGN	align technology inc	0.42	141,474	22,091,200	reduced	-2.21

ALKS	alkermes plc	0.00	6,594	184,500	unchanged	0.00

ALNY	alnylam pharmaceuticals inc	3.36	445,903	177,313,000	reduced	-0.14

AMGN	amgen inc	0.12	18,489	6,051,640	added	23.36

AMRX	amneal pharmaceuticals inc	0.00	7,913	99,704	unchanged	0.00

AMZN	amazon com inc	0.01	3,541	817,334	added	95.42

ANET	arista networks inc	0.01	4,800	628,944	new

ANNX	annexon inc	0.49	5,157,290	25,889,600	unchanged	0.00

ANTX	elevance health inc formerly	0.46	69,645	24,414,100	reduced	-33.65